Illumina | ILMN - Pre Tax Profit


Illumina reported $157M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Agilent USD 364M 78M Dec/2025
Bio Techne USD 50.78M 34.21M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Bruker USD 68.2M 140.8M Dec/2025
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Danaher USD 1.24B 138M Mar/2026
Dentsply International USD -42M 105M Mar/2026
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Illumina USD 157M 220M Mar/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Mettler Toledo International USD 329.07M 59.84M Dec/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quest Diagnostics USD 334M 4M Mar/2026
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 19.11M 2M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 264.18M 94.06M Dec/2025